Pharming (PHAR) EBT (2020 - 2025)
Historic EBT for Pharming (PHAR) over the last 6 years, with Q3 2025 value amounting to $22.9 million.
- Pharming's EBT rose 45664.56% to $22.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year increase of 12972.94%. This contributed to the annual value of -$8.6 million for FY2024, which is 6003.34% down from last year.
- According to the latest figures from Q3 2025, Pharming's EBT is $22.9 million, which was up 45664.56% from $3.8 million recorded in Q2 2025.
- Pharming's 5-year EBT high stood at $22.9 million for Q3 2025, and its period low was -$19.6 million during Q3 2021.
- In the last 5 years, Pharming's EBT had a median value of $960396.0 in 2021 and averaged -$509953.2.
- In the last 5 years, Pharming's EBT crashed by 31272.19% in 2021 and then soared by 3299099.44% in 2022.
- Over the past 5 years, Pharming's EBT (Quarter) stood at $12.8 million in 2021, then crashed by 241.49% to -$18.1 million in 2022, then skyrocketed by 70.24% to -$5.4 million in 2023, then crashed by 60.03% to -$8.6 million in 2024, then soared by 365.25% to $22.9 million in 2025.
- Its EBT stands at $22.9 million for Q3 2025, versus $3.8 million for Q2 2025 and -$7.0 million for Q1 2025.